Deltex Medical (GB:DEMG) has released an update.
Investor John Reilly has increased his stake in Deltex Medical Group plc to 5.18% by purchasing 5 million shares, as the company continues to innovate with its TrueVue System haemodynamic monitoring technology. The TrueVue System, which includes both minimally invasive and newly developed non-invasive devices, aims to enhance patient outcomes and hospital efficiency. Deltex Medical’s market expansion is driven by its technology’s application across diverse hospital settings and its new non-invasive technology, positioning it for broader adoption in healthcare.
For further insights into GB:DEMG stock, check out TipRanks’ Stock Analysis page.
